Protalix BioTherapeutics Inc (PLX)
1.18
-0.03
(-2.48%)
USD |
NYAM |
Apr 25, 16:00
1.20
+0.02
(+1.69%)
Pre-Market: 20:00
Protalix BioTherapeutics Free Cash Flow (Quarterly): 3.345M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.345M |
| September 30, 2023 | -7.335M |
| June 30, 2023 | 4.769M |
| March 31, 2023 | -3.246M |
| December 31, 2022 | -2.824M |
| September 30, 2022 | -9.262M |
| June 30, 2022 | -7.484M |
| March 31, 2022 | -6.058M |
| December 31, 2021 | -5.535M |
| September 30, 2021 | -2.224M |
| June 30, 2021 | 6.235M |
| March 31, 2021 | -10.22M |
| December 31, 2020 | -7.825M |
| September 30, 2020 | -3.706M |
| June 30, 2020 | -8.047M |
| March 31, 2020 | -7.183M |
| December 31, 2019 | -3.715M |
| September 30, 2019 | -3.617M |
| June 30, 2019 | -5.207M |
| March 31, 2019 | -7.446M |
| December 31, 2018 | -4.192M |
| September 30, 2018 | 13.54M |
| June 30, 2018 | -8.109M |
| March 31, 2018 | -9.662M |
| December 31, 2017 | 17.30M |
| Date | Value |
|---|---|
| September 30, 2017 | -10.68M |
| June 30, 2017 | -8.942M |
| March 31, 2017 | -8.646M |
| December 31, 2016 | -7.455M |
| September 30, 2016 | -3.60M |
| June 30, 2016 | -12.02M |
| March 31, 2016 | -9.876M |
| December 31, 2015 | -3.861M |
| September 30, 2015 | -8.788M |
| June 30, 2015 | -5.579M |
| March 31, 2015 | -6.52M |
| December 31, 2014 | -5.042M |
| September 30, 2014 | -9.794M |
| June 30, 2014 | -6.627M |
| March 31, 2014 | -8.603M |
| December 31, 2013 | -4.964M |
| September 30, 2013 | -8.543M |
| June 30, 2013 | -8.808M |
| March 31, 2013 | -10.23M |
| December 31, 2012 | 1.57M |
| September 30, 2012 | -8.799M |
| June 30, 2012 | 12.89M |
| March 31, 2012 | -7.091M |
| December 31, 2011 | -7.316M |
| September 30, 2011 | -9.132M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-10.22M
Minimum
Mar 2021
6.235M
Maximum
Jun 2021
-4.165M
Average
-5.207M
Median
Jun 2019
Free Cash Flow (Quarterly) Benchmarks
| Agenus Inc | -40.62M |
| InfuSystems Holdings Inc | 2.66M |
| Corbus Pharmaceuticals Holdings Inc | -6.009M |
| AIM ImmunoTech Inc | -9.956M |
| Armata Pharmaceuticals Inc | -10.51M |